Phio Pharmaceuticals Corp (PHIO)

[sabaidii2]

There is lots of discussion regarding the Immuno-oncology potential (RXI is still in the drug discovery phase, so I'm reluctant to call them "pipelines" just yet). And while deals do occur with pre-clinical drugs in this hot field, there's no way to judge the likelihood.

So, in the spirit of "Will an upfront money deal occur within our lifetimes?", I'm more focused on RXI-231, the skin-lightening cosmeceutical.

From the CC (http://investors.rxipharma.com/file/Index?KeyFile=37076476):
Pavco: "We were planning to start in the first quarter of the year and actually everything is in place except we haven't started the actual study so it should be starting within the month of April for sure. ... So it should go very quickly once we actually get started early in April."

A minor schedule slip.

Call-in Question: "Would it still take approximately six months from that April date to [get to the] conclusion?"
Pavco: "I would predict it will be quicker than that."

In my mind, we'll know soon enough whether RXI can deliver the goods. Shareholders may actually be rewarded.